dextroamphetamine has been researched along with Respiratory Distress Syndrome in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berton, AM | 1 |
| Prencipe, N | 1 |
| Giordano, R | 1 |
| Ghigo, E | 1 |
| Grottoli, S | 1 |
1 other study available for dextroamphetamine and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Amobarbital; Anti-Inflammatory Agents; COVID-19; COV | 2021 |